80 related articles for article (PubMed ID: 7970498)
1. Small cell lung cancer: analysis of factors influencing the response to treatment and survival.
de Wet M; Falkson G; Rapoport BL
Oncology; 1994; 51(6):523-34. PubMed ID: 7970498
[TBL] [Abstract][Full Text] [Related]
2. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
Spiegelman D; Maurer LH; Ware JH; Perry MC; Chahinian AP; Comis R; Eaton W; Zimmer B; Green M
J Clin Oncol; 1989 Mar; 7(3):344-54. PubMed ID: 2537384
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
Foster NR; Mandrekar SJ; Schild SE; Nelson GD; Rowland KM; Deming RL; Kozelsky TF; Marks RS; Jett JR; Adjei AA
Cancer; 2009 Jun; 115(12):2721-31. PubMed ID: 19402175
[TBL] [Abstract][Full Text] [Related]
5. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1991 Sep; 9(9):1618-26. PubMed ID: 1651993
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung cancer survival: 3 years as a minimum for predicting a favorable outcome.
Lewiński T; Zuławski M
Lung Cancer; 2003 May; 40(2):203-13. PubMed ID: 12711123
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis in limited disease (LD) small cell lung cancer (SCLC) patients according to status performance, local extension of lesions, type of treatment and the completeness of staging].
Remiszewski P; Roszkowski-Sliz K; Wiatr E; Roszkowska-Sliz B; Zych J; Kurzyna M; Jodkiewicz Z; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 2003; 71(3-4):139-47. PubMed ID: 14587419
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysis.
Hermes A; Waschki B; Gatzemeier U; Reck M
Lung Cancer; 2011 Mar; 71(3):363-6. PubMed ID: 20619477
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Paesmans M; Sculier JP; Lecomte J; Thiriaux J; Libert P; Sergysels R; Bureau G; Dabouis G; Van Cutsem O; Mommen P; Ninane V; Klastersky J
Cancer; 2000 Aug; 89(3):523-33. PubMed ID: 10931451
[TBL] [Abstract][Full Text] [Related]
10. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
[TBL] [Abstract][Full Text] [Related]
11. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials.
Tamura M; Ueoka H; Kiura K; Tabata M; Shibayama T; Miyatake K; Gemba K; Hiraki S; Harada M
Acta Med Okayama; 1998 Apr; 52(2):105-11. PubMed ID: 9588226
[TBL] [Abstract][Full Text] [Related]
13. [Cyclophosphamide, adriamycin and vincristine (CAV) in the treatment of small cell lung cancer].
Kawahara M; Tsuruta M; Furuse K; Arai R; Kodama N; Yamamoto M; Kubota K; Nakai R; Ogawara M
Gan To Kagaku Ryoho; 1988 Mar; 15(3):457-62. PubMed ID: 2831819
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
15. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos HP; Kosmidis P; Skarlos DV
Anticancer Res; 2002; 22(6B):3749-57. PubMed ID: 12552988
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study.
Maurer LH; Pajak TF
Cancer Treat Rep; 1981; 65(9-10):767-74. PubMed ID: 6268294
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
19. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
[TBL] [Abstract][Full Text] [Related]
20. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition.
Sculier JP; Chansky K; Crowley JJ; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2008 May; 3(5):457-66. PubMed ID: 18448996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
